HomeABBV • NYSE
AbbVie Inc
add
$183.76
0.83%
After Hours:(0.13%)+0.24
$184.00
Closed: Jun 23, 7:17:52 PM UTC-4 · USD · NYSE · Disclaimer
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 13.34B | 8.39% |
Operating expense | 5.28B | 8.44% |
Net income | 1.29B | -6.06% |
Net profit margin | 9.64 | -13.31% |
Earnings per share | 2.46 | 6.49% |
EBITDA | 6.10B | 11.89% |
Effective tax rate | 22.40% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 5.18B | -71.35% |
Total assets | 136.17B | -8.54% |
Total liabilities | 134.70B | -4.35% |
Total equity | 1.46B | — |
Shares outstanding | 1.77B | — |
Price to book | 231.63 | — |
Return on assets | 7.48% | — |
Return on capital | 14.21% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 1.29B | -6.06% |
Cash from operations | 1.64B | -59.53% |
Cash from investing | -735.00M | 92.33% |
Cash from financing | -1.26B | -111.63% |
Net change in cash | -349.00M | -106.64% |
Free cash flow | 1.12B | -73.12% |
Previous close
$185.30
Day range
$182.30 - $185.80
Year range
$163.52 - $218.66
Market cap
324.59B USD
Avg Volume
6.31M
P/E ratio
78.36
Dividend yield
3.57%
Primary exchange
NYSE
About
AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. Its major products are: Humira, approved to treat autoimmune diseases including rheumatoid arthritis, Crohn's disease, plaque psoriasis, and ulcerative colitis and administered via injection; Skyrizi, an interleukin-23 inhibitor also used to treat autoimmune diseases; Rinvoq, used to treat arthritis; and Botox. Its other major products include Imbruvica to treat cancer, Vraylar to treat schizophrenia and bipolar disorder, Venclexta to treat leukemia and lymphoma, and Mavyret to treat Hepatitis C. The company is also committed to product development for other treatments of cancer, neurologic diseases, eye care, and cystic fibrosis.
The company is ranked sixth on the list of largest biomedical companies by revenue. It is ranked 108th on the Forbes Global 2000.
The name "AbbVie" is derived from a combination of "Abbott", the name of its former parent company, with "vie", intended as a reference to a Latin root meaning 'life'. Wikipedia
Founded
Apr 10, 2012
Headquarters
Website
Employees
55,000
